MedMira Inc.
155 Chain Lake Drive
Halifax
Nova Scotia
B3S 1B3
Canada
Tel: 902-450-1588
Fax: 902-450-1580
Website: http://www.medmira.com/
Email: ir@medmira.com
129 articles about MedMira Inc.
-
MedMira’s July 2020 Update as per the IIROC Request
7/10/2020
MedMira Inc. would like to issue a statement to address the request form the Investment Industry Regulatory Organization of Canada and comment on the recent increase in the price of the company’s shares.
-
MedMira Reports Third Quarter Results FY2020
6/30/2020
MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended April 30, 2020.
-
MedMira Announces Exclusive Distribution Partnership with Webb Diagnostic Technologies and Initial Order for REVEALCOVID-19™ Total Antibody Test in the U.S.
5/27/2020
MedMira Inc. (MedMira) (TSXV: MIR) announces that company has entered into an Exclusive Distribution Agreement with Webb Diagnostic Technologies, Inc., (WebbDX) for the distribution of MedMira’s REVEALCOVID-19™ Total Antibody Test.
-
MedMira Announces Progress Update of its REVEALCOVID-19™ Total Antibody Test Including CE Mark
5/21/2020
Today, MedMira Inc. (MedMira) (TSXV: MIR) announced that it has completed the registration process and affixed the CE mark (Conformité Européene) to its rapid REVEALCOVID-19™ Total Antibody Test.
-
MedMira Announces Notification Submission to US FDA Emergency Use Authorization
4/23/2020
MedMira Inc., announced that it had submitted the notification for the Emergency Use Authorization application offered by the U.S. Food and Drug Administration for its newest member of its Reveal line of products for antibody testing.
-
MedMira Announces Update on Development of Point-of-Care Antibody Test
4/16/2020
MedMira Inc. (MedMira) (TSXV: MIR), announced today that it has completed the development of the serological Point-of-Care (POC) testing solution with immediate result. Based on MedMira’s unique and patented Rapid Vertical Flow® (RVF) technology, the newly developed REVEALCOVID-19TM delivers immediate results without the need for any additional equipment such as a reader or a timer.
-
MedMira Reports Second Quarter Results FY2020
3/31/2020
MedMira Inc., reported on its financial results for the quarter ended January 31, 2020.
-
MedMira Reports First Quarter Results FY2020
12/31/2019
MedMira Inc., reported on its financial results for the quarter ended October 31, 2019.
-
MedMira Reports 2019 Fourth Quarter and Year End Financial Results
11/29/2019
MedMira Inc., reported on its financial results for the financial year ended July 31, 2019.
-
MedMira Announces AGM Results and Stock Option Grant
2/2/2018
Incumbent Directors Mr. Hermes Chan and Dr. Shou-Ching Tang were re-elected and Ms. Lili Zhao was elected to the Board during the meeting.
-
MedMira Reports First Quarter Results
12/27/2017
In Q1 FY2018, the Company recorded revenue of $143,042 compared to $212,245 in Q1 FY2017.
-
MedMira Reports 2017 Fourth Quarter and Year End Financial Results
11/29/2017
Total product revenues recorded for FY2017 were $747,344 compared to $962,140 in FY2016.
-
MedMira Inc. Announces Annual Shareholders Meeting Results
2/2/2016
-
MedMira Inc. Opens US Subsidiary In Atlanta, GA
7/20/2015
-
MedMira Inc. Expands U.S. Growth Plan With New Equity Investment From Onsite Lab
3/31/2015
-
MedMira Inc. Embarks on Major U.S. Expansion With VWR International, Inc. Agreement
1/13/2014
-
MedMira Inc. Announces Year End Results
12/1/2009
-
MedMira Inc. Strengthens North American Sales Channels, Adding VWR International, Inc. as Distributor for the United States
5/29/2009
-
MedMira Inc. Moves Forward with Outsourced Manufacturing Strategy
1/28/2009
-
MedMira Inc. Announces Grant of Employee Stock Options
1/5/2009